{{Rsnum
|rsid=17506395
|Gene=TP63
|Chromosome=3
|position=189803530
|Orientation=plus
|GMAF=0.1455
|Gene_s=TP63
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 12.4 | 37.2 | 50.4
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 17.7 | 82.3
| ASW | 0.0 | 24.6 | 75.4
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 20.8 | 79.2
| LWK | 0.0 | 18.2 | 81.8
| MEX | 0.0 | 17.2 | 82.8
| MKK | 0.0 | 25.0 | 75.0
| TSI | 6.9 | 41.2 | 52.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24316488
|Title=A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis
}}

{{PMID Auto
|PMID=25218545
|Title=Interaction between TP63 and MDM2 genes and the risk of recurrent pregnancy loss
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}